Robin Prestwich - Concepedia

Author

Robin Prestwich

Also Known As

R J D Prestwich, R J Prestwich, R Prestwich, R. J. D. Prestwich, R. J. Prestwich, R. Prestwich, R.J Prestwich, R.J. Prestwich, R.J.D. Prestwich, Robin J D Prestwich

165

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

St James's University Hospital University of Leeds Leeds Teaching Hospitals NHS Trust Institute of Cancer Research University of Surrey

About

Robin Prestwich is an author at St James's University Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1.2K
2	Health Sciences	13	14	419
3	Engineering	2	2	55
4	Cell Biology	2	2	131
5	Gastroenterology	1	1	54

Robin Prestwich

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients Robert A. Adair, Victoria Roulstone, Karen J. Scott, Science Translational Medicine Viral ReplicationImmunologyPathologyVivo Immune EvasionImmunotherapy	2012	192
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity Robin Prestwich, Fiona Errington‐Mais, Elizabeth J. Ilett, Clinical Cancer Research	2008	186
Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity Fiona Errington‐Mais, Lynette P. Steele, Robin Prestwich, The Journal of Immunology	2008	185
Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication Robin Prestwich, Elizabeth J. Ilett, Fiona Errington‐Mais, Clinical Cancer Research	2009	183
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity Elizabeth J. Ilett, Robin Prestwich, Timothy Kottke, Gene Therapy T CellsImmunologyTumor ImmunityTherapeutic VaccineVirology	2009	122
Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers Kevin J. Harrington, Eleni Karapanagiotou, Victoria Roulstone, Clinical Cancer Research	2010	118
Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action Lisa Collis, Christine Hall, Laurie Lange, FEBS Letters	1998	111
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma Charles L. White, Katie Twigger, Ailsa Rose, Gene Therapy Inflammatory Tumour CellMelanomaImmunologyVirologyOncolytic Reovirus	2008	103
Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma Hardev Pandha, Lucy Heinemann, Guy R. Simpson, Clinical Cancer Research	2009	97
Reciprocal Human Dendritic Cell–Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus Robin Prestwich, Fiona Errington‐Mais, Lynette P. Steele, The Journal of Immunology ImmunologyImmune RegulationNk CellsImmunologic MechanismInnate Immunity	2009	77

Page 1